AZD0585 Phase III Long-term Study in Japan
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 383 participants.
Also called NCT02463071
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 383 participants
- Sponsor
- Registry
-
NCT02463071
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02463071. Randomized; double masking; primary purpose treatment. Start 2015-06-10 (actual); primary completion 2017-03-11 (actual). Results posted on 2018-10-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AZD0585 Phase III Long-term Study in Japan
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- AZD0585
- Intervention (Drug)
- AZD0585 placebo
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct02463071- Content hash
127b9ed47d0939eb05b433f3e101c013651168eccd91e33f3a83cbe86ccafbbc